ACXP
Acurx Pharmaceuticals, Inc.
$1.45
-0.13 (-8.23%)
At close · Jul 7
Market Cap
$6.23M
Shares
4,297,738
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$7.97M
+43.5%
FY2025
Diluted EPS
-$5.32
+69.4%
FY2025
Operating Cash Flow
-$6.79M
+34.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $1.58M | $1.83M | $5.4M | $6.04M | $4.75M | $2.03M | |
| $6.05M | $6.26M | $8.7M | $8.53M | $7.34M | $10.78M | |
| — | — | — | — | — | $208.27K | |
| $7.63M | $8.09M | $14.1M | $14.58M | $12.09M | $12.81M | |
| -$7.63M | -$8.09M | — | — | — | — | |
| $133.16K | $125.45K | — | — | — | — | |
| — | — | — | — | $0 | $0 | |
| -$7.5M | -$7.97M | -$14.1M | -$14.58M | -$12.09M | -$12.75M | |
| USD/shares | — | -$5.32 | -$17.40 | -$23.00 | -$22.40 | -$29.80 |
| USD/shares | — | -$5.32 | -$17.40 | -$23.00 | -$22.40 | -$29.80 |
| shares | — | 1.5M | 808.17K | 633.58K | 540.82K | 426.79K |
| shares | — | 1.5M | 808.17K | 633.58K | 540.82K | 426.79K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.